Behavioral and neurochemical effects of proline

被引:75
作者
Wyse, Angela T. S. [1 ]
Netto, Carlos Alexandre [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Lab Neuroprotecao & Doencas Metabol, BR-90035003 Porto Alegre, RS, Brazil
关键词
Proline; Hyperprolinemia; Brain damage; Antioxidants; Alpha-tocopherol; Ascorbic acid; CENTRAL-NERVOUS-SYSTEM; ATP-DIPHOSPHOHYDROLASE ACTIVITY; ALZHEIMERS-DISEASE BRAIN; SYNAPTIC PLASMA-MEMBRANE; SODIUM-DEPENDENT PROLINE; CREATINE-KINASE ACTIVITY; HYPERPROLINEMIA TYPE-I; OXYGEN-FREE RADICALS; RAT CEREBRAL-CORTEX; VITAMIN-E;
D O I
10.1007/s11011-011-9246-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proline is an amino acid with an essential role for primary metabolism and physiologic functions. Hyperprolinemia results from the deficiency of specific enzymes for proline catabolism, leading to tissue accumulation of this amino acid. Hyperprolinemic patients can present neurological symptoms and brain abnormalities, whose aetiopathogenesis is poorly understood. This review addresses some of the findings obtained, mainly from animal studies, indicating that high proline levels may be associated to neuropathophysiology of some disorders. In this context, it has been suggested that energy metabolism deficit, Na+,K+-ATPase, kinase creatine, oxidative stress, excitotoxicity, lipid content, as well as purinergic and cholinergic systems are involved in the effect of proline on brain damage and spatial memory deficit. The discussion focuses on the relatively low antioxidant defenses of the brain and the vulnerability of neural tissue to reactive species. This offers new perspectives for potential therapeutic strategies for this condition, which may include the early use of appropriate antioxidants as a novel adjuvant therapy, besides the usual treatment based on special diets poor in proline.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 202 条
[1]  
ABBRACCHIO MP, 2009, Int J Neurosci, V32, P683
[2]   METABOLISM OF PROLINE AND THE HYDROXYPROLINES [J].
ADAMS, E ;
FRANK, L .
ANNUAL REVIEW OF BIOCHEMISTRY, 1980, 49 :1005-1061
[3]  
Adams E, 1970, Int Rev Connect Tissue Res, V5, P1
[4]   Adenosine triphosphate - Established and potential clinical applications [J].
Agteresch, HJ ;
Dagnelie, PC ;
van den Berg, JWO ;
Wilson, JHP .
DRUGS, 1999, 58 (02) :211-232
[5]   Oxidative modification of creatine kinase BB in Alzheimer's disease brain [J].
Aksenov, M ;
Aksenova, M ;
Butterfield, DA ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2520-2527
[6]   Oxidative stress and its role in the pathogenesis of ischaemic stroke [J].
Allen, C. L. ;
Bayraktutan, U. .
INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (06) :461-470
[7]   Morphoregulation by acetylcholinesterase in fibroblasts and astrocytes [J].
Anderson, Alexandra A. ;
Ushakov, Dmitry S. ;
Ferenczi, Michael A. ;
Mor, Ryoichi ;
Martin, Paul ;
Saffell, Jane L. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 215 (01) :82-100
[8]  
Anderson CM, 2000, GLIA, V32, P1
[9]   New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target [J].
Aperia, A. .
JOURNAL OF INTERNAL MEDICINE, 2007, 261 (01) :44-52
[10]   CHANGES IN ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE IN ALZHEIMERS-DISEASE RESEMBLE EMBRYONIC-DEVELOPMENT - A STUDY OF MOLECULAR-FORMS [J].
ARENDT, T ;
BRUCKNER, MK ;
LANGE, M ;
BIGL, V .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (03) :381-396